I agree with you Jonzo. He played correctly the cards he's been delt with.
- He can't talk about FDA
- He can't talk about Partnerships
- He can't talk about buyout discussions
- He can't name and bash the hedgefund
- He doest have a dime in the companys bank account
- The best tidbit of results were already disclosed (Renal and SGLT2)
- COVID is a longshot and takes time.
So basically, the question we have to ask ourselves is :what do you think is worth a post, failed, phase 3 drug, with BTD, in a large critical unmet need?
150M CAD like the TSX showing right now? No way. Lets all go to sleep with our lottery tickets and wake up when FDA/BP/RVX deal is done.